PROM1 and brain glioblastoma: Itai et al. established a novel anti-CD133 mouse monoclonal antibody of immunoglobulin G (IgG), namely CMab-43 (IgG2a, kappa), possessing a high sensitivity and specificity against immunized BALB/c nude mice with CD133-expressing LN229 brain glioblastoma cells [161].